[1]
M. Folqué, “‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up”, Allergol Immunopathol, vol. 47, no. 4, pp. 336–341, Aug. 2019, Accessed: Apr. 26, 2026. [Online]. Available: https://www.all-imm.com/index.php/aei/article/view/299